What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer
Proceedings from a live event on June 1, 2024, held during the ASCO 2024 Annual Meeting and moderated by Dr Andrew J Armstrong. Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Dr Andrew J Armstrong, Dr Tanya B Dorff and Dr Matthew R Smith, moderated by Dr Armstrong. Published June 28, 2024.
Topics:
• Introduction (0:00)
• Optimizing the Management of Nonmetastatic Prostate Cancer — Dr Dorff (3:34)
• Evidence-Based Selection of Treatment for Metastatic Hormone-Sensitive Prostate Cancer — Dr Smith (26:32)
• New Considerations with the Use of PARP Inhibitors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Dr Agarwal (53:27)
• Role of Novel Radiopharmaceuticals for mCRPC — Dr Armstrong (1:15:36)
• Promising Investigational Approaches for Patients with Prostate Cancer — Dr Antonarakis (1:36:43)
The entire program, slides, CME information, and, select publications:
[ Ссылка ]
